DOSIMETRY OF I-123 IOMAZENIL IN HUMANS

被引:11
作者
VERHOEFF, NPLG
SOKOLE, EB
HENGST, D
STUBBS, JB
VANROYEN, EA
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT RADIAT SAFETY,1105 AZ AMSTERDAM,NETHERLANDS
[2] OAK RIDGE INST SCI & EDUC,OAK RIDGE,TN
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1993年 / 20卷 / 07期
关键词
DOSIMETRY; I-123; RECEPTORS; BENZODIAZEPINE; FLUMAZENIL; IOMAZENIL;
D O I
10.1007/BF00176551
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The distribution of the central benzodiazepine receptor specific ligand iodine-123 iomazenil was investigated in seven human adults from whole-body scans, blood samples and urine collected up to 24 h after injection. Using 12 source organs, the MIRD method was applied to calculate the absorbed radiation dose of the radioligand in various organs. The urinary bladder wall (0.15 mGy/MBq), lower large intestinal wall (0.071 mGy/MBq) testes (0.044 mGy/MBq) and upper large intestined wall (0.038 mGy/MBq) received the highest absorbed doses. The average effective dose equivalent of I-123-IBZM for adults was estimated to be 0.033 mSv/MBq.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 19 条
[11]   IMAGING OF [C-11]-LABELED RO 15-1788 BINDING TO BENZODIAZEPINE RECEPTORS IN THE HUMAN-BRAIN BY POSITRON EMISSION TOMOGRAPHY [J].
PERSSON, A ;
EHRIN, E ;
ERIKSSON, L ;
FARDE, L ;
HEDSTROM, CG ;
LITTON, JE ;
MINDUS, P ;
SEDVALL, G .
JOURNAL OF PSYCHIATRIC RESEARCH, 1985, 19 (04) :609-&
[12]   INVIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR-BINDING IN HUMAN EPILEPTIC FOCI [J].
SAVIC, I ;
ROLAND, P ;
SEDVALL, G ;
PERSSON, A ;
PAULI, S ;
WIDEN, L .
LANCET, 1988, 2 (8616) :863-866
[13]   EVALUATION OF A MULTICENTER STUDY WITH IOMAZENIL - A BENZODIAZEPINE RECEPTOR LIGAND [J].
SCHUBIGER, PA ;
HASLER, PH ;
BEERWOHLFAHRT, H ;
BEKIER, A ;
OETTLI, R ;
CORDES, M ;
FERSTL, F ;
DEISENHAMMER, E ;
DEROO, M ;
MOSER, E ;
NITZSCHE, E ;
PODREKA, I ;
RICCABONA, G ;
BANGERL, I ;
SCHOBER, O ;
BARTENSTEIN, P ;
VANRIJK, P ;
VANISSELT, JW ;
VANROYEN, EA ;
VERHOEFF, NPLG ;
HALDEMANN, R ;
VONSCHULTHESS, GK .
NUCLEAR MEDICINE COMMUNICATIONS, 1991, 12 (07) :569-582
[14]  
VERHOEFF NPL, IN PRESS NUCL MED CO
[15]  
VERHOEFF NPL, 1992, NUKLEARMED-NUCL MED, V28, P175
[16]  
VERHOEFF NPLG, 1991, NUCL MED SUPPL, V27, P203
[17]  
VERHOEFF NPLG, 1992, NUCL EMD S, V28, P179
[18]  
1992, PRECRIPTION DRUGS HU, P221
[19]  
1977, WHO TECHNICAL REPORT, V611